| Primary |
| Drug Use For Unknown Indication |
48.2% |
| Product Used For Unknown Indication |
13.4% |
| Hypertension |
12.5% |
| Angina Pectoris |
9.8% |
| Cardiac Failure |
6.3% |
| Hypothyroidism |
1.8% |
| Staphylococcal Infection |
1.8% |
| Arteritis |
0.9% |
| Atrial Flutter |
0.9% |
| Blood Cholesterol Increased |
0.9% |
| Cardiovascular Event Prophylaxis |
0.9% |
| Coronary Arterial Stent Insertion |
0.9% |
| Essential Hypertension |
0.9% |
| Myocardial Infarction |
0.9% |
|
| Weight Decreased |
13.8% |
| Orthostatic Hypotension |
10.3% |
| Thrombocytopenia |
10.3% |
| Rash Maculo-papular |
6.9% |
| Urinary Tract Infection |
6.9% |
| Bradycardia |
3.4% |
| Cardiac Failure |
3.4% |
| Electrocardiogram Qrs Complex Prolonged |
3.4% |
| Gamma-glutamyltransferase Increased |
3.4% |
| Hypothermia |
3.4% |
| Myoclonus |
3.4% |
| Oedema Peripheral |
3.4% |
| Osteonecrosis |
3.4% |
| Overdose |
3.4% |
| Pain In Extremity |
3.4% |
| Polyneuropathy |
3.4% |
| Pyelonephritis |
3.4% |
| Raynaud's Phenomenon |
3.4% |
| Renal Failure |
3.4% |
| Seborrhoeic Dermatitis |
3.4% |
|
| Secondary |
| Cardiac Disorder |
13.5% |
| Hypertension |
13.5% |
| Drug Use For Unknown Indication |
11.6% |
| Ill-defined Disorder |
6.8% |
| Breast Cancer Metastatic |
6.3% |
| Product Used For Unknown Indication |
5.3% |
| Cardiac Failure |
4.3% |
| Congestive Cardiomyopathy |
4.3% |
| Depression |
4.3% |
| Hiv Infection |
4.3% |
| Psychotic Disorder |
4.3% |
| Hypercholesterolaemia |
3.4% |
| Atrial Fibrillation |
2.9% |
| Hypothyroidism |
2.9% |
| Myocardial Ischaemia |
2.4% |
| Acute Myocardial Infarction |
1.9% |
| Cardiac Failure Chronic |
1.9% |
| Colon Cancer |
1.9% |
| Osteoporosis |
1.9% |
| Rheumatoid Arthritis |
1.9% |
|
| Polyneuropathy |
9.3% |
| Thrombocytopenia |
9.3% |
| Vomiting |
9.3% |
| Disseminated Intravascular Coagulation |
7.0% |
| Oedema Peripheral |
7.0% |
| Osteonecrosis |
7.0% |
| Syncope |
7.0% |
| Urinary Retention |
7.0% |
| Gamma-glutamyltransferase Increased |
4.7% |
| Headache |
4.7% |
| Myocardial Infarction |
4.7% |
| Subdural Haematoma |
4.7% |
| Electrocardiogram Abnormal |
2.3% |
| Fatigue |
2.3% |
| Neutropenia |
2.3% |
| Orthostatic Hypotension |
2.3% |
| Pleural Effusion |
2.3% |
| Pyrexia |
2.3% |
| Rash Maculo-papular |
2.3% |
| Septic Shock |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.4% |
| Hypertension |
13.7% |
| Product Used For Unknown Indication |
11.4% |
| Hypercholesterolaemia |
9.4% |
| Cardiac Failure |
5.3% |
| Rheumatoid Arthritis |
5.1% |
| Diabetes Mellitus |
4.9% |
| Myocardial Ischaemia |
4.0% |
| Ischaemic Cardiomyopathy |
3.5% |
| Prophylaxis |
3.3% |
| Multiple Myeloma |
2.6% |
| Thrombosis Prophylaxis |
2.4% |
| Left Ventricular Dysfunction |
2.2% |
| Breast Cancer |
2.1% |
| Hiv Infection |
2.0% |
| Benign Prostatic Hyperplasia |
1.9% |
| Neuralgia |
1.9% |
| Hepatic Neoplasm Malignant |
1.8% |
| Pain |
1.7% |
| Abdominal Pain |
1.5% |
|
| Renal Failure |
15.3% |
| Sensory Loss |
10.2% |
| Pneumonia |
8.0% |
| Vomiting |
8.0% |
| Confusional State |
6.6% |
| Ventricular Fibrillation |
5.8% |
| Weight Decreased |
5.8% |
| Renal Failure Acute |
5.1% |
| Nervous System Disorder |
4.4% |
| Sensory Disturbance |
4.4% |
| Syncope |
3.6% |
| Death |
2.9% |
| Multi-organ Failure |
2.9% |
| Septic Shock |
2.9% |
| Weight Increased |
2.9% |
| Anaemia Haemolytic Autoimmune |
2.2% |
| Hypothermia |
2.2% |
| Pyrexia |
2.2% |
| Rash Maculo-papular |
2.2% |
| Respiratory Failure |
2.2% |
|
| Interacting |
| Ill-defined Disorder |
90.9% |
| Angina Pectoris |
9.1% |
|
|
